BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 88 filers reported holding BIODELIVERY SCIENCES INTL IN in Q4 2018. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $118,000 | -3.3% | 37,948 | +13.1% | 0.00% | – |
| Q3 2021 | $122,000 | +1.7% | 33,548 | 0.0% | 0.00% | – |
| Q2 2021 | $120,000 | -35.5% | 33,548 | -29.1% | 0.00% | – |
| Q1 2021 | $186,000 | -5.1% | 47,348 | +1.2% | 0.00% | – |
| Q4 2020 | $196,000 | +21.0% | 46,800 | +8.3% | 0.00% | – |
| Q3 2020 | $162,000 | +12.5% | 43,200 | +31.7% | 0.00% | – |
| Q2 2020 | $144,000 | +63.6% | 32,800 | +42.6% | 0.00% | – |
| Q1 2020 | $88,000 | -24.1% | 23,000 | +26.4% | 0.00% | – |
| Q4 2019 | $116,000 | -54.2% | 18,200 | -69.7% | 0.00% | – |
| Q3 2019 | $253,000 | +80.7% | 60,000 | +100.0% | 0.00% | – |
| Q2 2019 | $140,000 | -41.4% | 30,000 | -33.3% | 0.00% | – |
| Q1 2019 | $239,000 | +24.5% | 45,000 | -13.5% | 0.00% | – |
| Q4 2018 | $192,000 | +37.1% | 52,000 | +4.0% | 0.00% | – |
| Q3 2018 | $140,000 | -5.4% | 50,000 | 0.0% | 0.00% | – |
| Q2 2018 | $148,000 | – | 50,000 | +36131.9% | 0.00% | – |
| Q2 2016 | $0 | – | 138 | -4.2% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 144 | +3.6% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 139 | -37.9% | 0.00% | – |
| Q3 2015 | $1,000 | -50.0% | 224 | +2.3% | 0.00% | – |
| Q2 2015 | $2,000 | 0.0% | 219 | +45.0% | 0.00% | – |
| Q1 2015 | $2,000 | 0.0% | 151 | 0.0% | 0.00% | – |
| Q4 2014 | $2,000 | -98.9% | 151 | -98.5% | 0.00% | – |
| Q3 2014 | $178,000 | – | 10,388 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Capital Management | 1,000 | $3,000 | 0.00% |
| Close Asset Management Ltd | 7,500 | $23,000 | 0.00% |
| IFP Advisors, Inc | 250 | $1,000 | 0.00% |